NLCP: TAKE A LOOK

NLCP: Take a look... by StockBlog on TradingView.com

What starts out nice, often ends in pain. NLCP stock owns and leases medical cannabis facilities. It started out crazy, but now it might be worth watching. It is in an industry with a future, but as you know, it is not worth giving a lot of money for the future, as it was in 2021, when it was listed on the stock market.

At the moment, however, her sizes look good. It has two million loans and 450 million in cash. It has a dividend yield of 12% paying 83% of its earnings in dividends, a P/E of 12 and a P/BV of 0.6. It trades five times its sales, but reasonable for a development company.

It is a relatively high-risk option with several possibilities of reversal if the figures improve in the future and the forecasts are verified. Now that much of the joy is deflating, it might be time to capitalize on the regret of the shareholders who bought at 32!

On the radar...

Timing the market is practically and emotionally impossible

 As the Danish philosopher Soren Kierkegaard noted, life can only be understood backwards – but we must live it forwards.  Looking back, you can always see exactly when you should have bought and sold your shares.  But don't be fooled into thinking you're able to see in real time exactly when to do it.  In financial markets, hindsight is always clear, but foresight is legally blind.  Consequently, for most investors, timing the market is practically and emotionally impossible."

Benjamin Graham 

Jumbo : 20% more sales in 7 months...

 

Anything that inflates suddenly, without logic, ends up like this...

 Anything that inflates suddenly, without logic, ends up like this... Ok batteries are the future. But the competition is great and the development companies have a lot of risk ... Despite the dip, it remains overvalued and can probably go even lower. Cash at 100 million, debt at 800. In the 10% of high-risk and contrarian stocks that a portfolio can contain...

During this period Mytileneos is unstoppable

New all-time highs... Patience, Study and Confidence in your moves.  In this particular case it took 13 years for the stock to prove its worth.  In 2012 it had one and a half euros, 2015 and 2019 5 euros.

 At this price and based on fundamentals, the stock is fairly priced.  For retention, fine.  We buy when there are sales ;) .  However, based on the dividend it gives and its balance sheet, if it were listed in America, it should have 100 euros or more... But that's America and they like to do crazy things... 🤪